1Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935; 29:181 - 191.
2Legm RS. Polycystic ovary syndrome Phenotype to geno- type. Endocrinol Metab Clin North Am 1999 Jun;28(2) :379 -396.
3Conway GS, Honour JW, Jacobs HS. Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clin Endocrinol (Oxf) 1989;30:459 -470.
4Burghen GA, Givens JR, Kitabchi AE. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab 1980 Jan;50(1) :113 -116.
5Zawadzki JK, Dunaif A 1992 Diagnostic criteria for polycystie ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome. Oxford, UK: Blackwell; 59-69.
6The Rotterdam ESHRE/ASRM - sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long, term health risks related to polycystic ovary syndrome (P- COS). Hum Rcprod 2004;19:41 -47.
7Azziz R, Carmina E, Dewailly D, Diamanti - Kandarakis E, et al. Position statement: criteria for defining polyeystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006 ;91:4237 - 4245.
8Escobar- Morreale HF, Botella -CarreteroJI, Alvarez - Blasco F,et al. The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery. J Clin Endocrinol Metab 2005 ;90:6364 - 6369.
9Hoeger KM: Obesity and lifestyle management in polycystic ovary syndrome. Clin Obstet Gynecol 2007 ;50:277 -294.
10Marsden PJ, Murdoeh A, Taylor R. Metabolism. 1994 Dee; 43 (12) :1536 -42. Severe impairment of insulin action in adipoeytes from amenorrheic subjects with polycystic ovary syndrome.
5Mastorakos G,Lambrinoudaki I,Creatsas G.Polycystic ovarysyndrome in adolescents:current and future treatment options[J].Pediatric Drugs,2006,8(5):311-318.
6Stein IF,Leventhal ML.Amenorrhea associated with bilateralpolycystic ovaries[J].Obstet Gynecol,1935,29:181-191.
7McArthur JW,Ingersoll FM,Worcester J.The urinaryexcretion of interstitial-cell and follicle-stimulating hormoneactivity by women with diseases of the reproductive system[J].Clin Endocrinol Metal,1958,18:1202-1215.
8Berger MJ,Taymor ML,Patton WC.Gonadotropin levels andsecretory patterns in patients with typical and atypical polycysticovarian disease[J].Fertil Steril,1975,26:619-626.
9Zawadzki JK,Dunaif A.Diagnostic criteria for polycysticovary syndrome:towards a rational approach.In:Dunaif A,Givens JR,Haseltine F,et al.Polycystic Ovary Syndrome[M].Cambridge,MA:Blackwell Scientific,1992:377-384.
10Azziz R,Carmina E,Dewailly D,et al.ositions statement:criteria fordefining polycystic ovary syndrome as a predominantlyhyperandrogenic syndrome:an androgen excess societyguidelin[J].J Clin Endocrinol Metab,2006,91(11):4237-4245.
